OACC
Oaktree Acquisition Corp. III Life Sciences
1W: +0.0%
1M: +1.1%
3M: +0.6%
YTD: +0.8%
1Y: +5.4%
$10.70
+0.00 (+0.00%)
After Hours: $11.80 (+1.10, +10.28%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$263.3M
52W Range10.04-10.736
Volume1,599
Avg Volume32,225
Beta0.62
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZaid Pardesi
Employees3
SectorFinancial Services
IndustryShell Companies
IPO Date2024-12-16
333 South Grand Avenue
Los Angeles, CA 90071
US
Los Angeles, CA 90071
US
213 830 6300
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Martinez George Arth | 0 | — | 2025-10-29 | |
| BERRY DAVID A | 0 | — | 2025-10-17 | |
| Sweeney Thomas | 0 | — | 2025-06-03 | |
| Oaktree Acquisition | J-Other | 231,492 | — | 2024-10-30 |
| Oaktree Acquisition | C-Conversion | 33,981 | $10.00 | 2024-10-30 |